Systemic health, ageing and environment — what your skin is trying to tell you
Skin changes are frequently the earliest visible signal of underlying systemic disease. Thyroid dysfunction, insulin resistance and blood glucose dysregulation each produce characteristic skin presentations that do not resolve with topical treatment — because the driver is systemic. Understanding the systemic picture, the biology of skin ageing, and the environmental factors that accelerate it, is essential for any skin condition that has not responded to standard treatment.
Thyroid dysfunction and skin
Thyroid hormones regulate the metabolic rate of every cell in the body, including the keratinocytes, fibroblasts and melanocytes of the skin. Thyroid hormone receptors (TRalpha and TRbeta) are expressed throughout the epidermis and dermis, making skin one of the most hormonally sensitive thyroid target organs.
Hypothyroidism reduces keratinocyte proliferation and differentiation rate, producing the classic dry, rough, thickened skin associated with inadequate thyroid function. Reduced metabolic rate also decreases sweating, reduces sebaceous gland activity and impairs the active transport mechanisms that deliver nutrients to the dermis. In the dermis, reduced thyroid signalling decreases fibroblast activity and collagen turnover, producing the dull, inelastic skin quality characteristic of hypothyroidism. Reduced metabolic rate also impairs gut motility and nutrient absorption, compounding nutritional deficiencies that independently affect skin function.
Critically, subclinical hypothyroidism — elevated TSH with normal free T4, falling within standard laboratory reference ranges — produces the full spectrum of thyroid skin symptoms without meeting the diagnostic threshold for overt hypothyroidism. A 2019 review in Thyroid Research confirmed that subclinical hypothyroidism produces measurable reductions in skin hydration, collagen content and barrier function, and that normalisation of thyroid function produces objective improvement in these parameters. Assessment of free T3, free T4, reverse T3 and thyroid antibodies (TPO and TG) is required to identify the subclinical and autoimmune thyroid dysfunction that standard TSH-only testing misses.
Blood glucose, insulin and skin
The relationship between blood glucose dysregulation and skin ageing operates through a process called glycation — the non-enzymatic binding of glucose molecules to proteins, including collagen and elastin. Glycated proteins form advanced glycation end-products (AGEs) that are structurally stiff, resistant to normal enzymatic breakdown and highly pro-inflammatory through their interaction with RAGE (receptor for advanced glycation end-products) on skin cells.
AGE accumulation in the dermis produces visibly yellowed, stiff, wrinkled skin that ages faster than chronological age would predict — a phenomenon measurable by skin autofluorescence and directly correlated with HbA1c levels in population studies. A 2011 study in the British Journal of Dermatology confirmed that skin autofluorescence — a proxy for AGE accumulation — was significantly higher in type 2 diabetes patients compared to age-matched controls, and that elevated skin AGE levels were independently predictive of cardiovascular and microvascular complications.
Postprandial blood glucose spikes — even in individuals without diabetes — drive transient AGE formation that compounds over time. A low-glycaemic dietary framework reduces AGE formation rate, with evidence from randomised trials showing measurable reductions in skin AGE accumulation within 12 weeks of dietary intervention.
The biology of skin ageing
Chronological skin ageing is driven by the gradual decline in fibroblast activity, collagen and elastin production, hyaluronic acid synthesis and antioxidant capacity that occurs with age. From the third decade, collagen production decreases by approximately 1% annually. From perimenopause, the rate of collagen loss accelerates significantly — approximately 30% of dermal collagen is lost in the first five years following menopause, driven by oestrogen withdrawal from the collagen-stimulating mechanisms described in the hormones article.
The distinction between intrinsic (chronological) ageing and extrinsic (photoageing and environmental) ageing is clinically important because the interventions differ. Intrinsic ageing requires collagen precursor support (vitamin C, glycine, proline), growth factor stimulation, and reduction of the oxidative and inflammatory processes that accelerate fibroblast senescence. Extrinsic ageing requires photoprotection, DNA repair support and targeted antioxidant intervention at the sites of UV-driven oxidative damage.
Photoageing and UV damage
UV radiation causes photoageing through two primary mechanisms: direct DNA damage to skin cells (producing mutations that impair normal keratinocyte function) and UV-induced reactive oxygen species (ROS) that activate matrix metalloproteinases (MMPs) to degrade existing collagen and elastin. Both mechanisms are distinct from chronological ageing and together account for the majority of visible skin ageing in sun-exposed populations.
UVA radiation (320-400nm) penetrates to the dermis and is the primary driver of photoageing — it generates ROS that activate MMP-1, MMP-3 and MMP-9, degrading dermal collagen and elastin and disrupting the extracellular matrix organisation that gives skin its structural integrity. UVB (280-320nm) causes direct DNA damage producing cyclobutane pyrimidine dimers (CPDs) that if unrepaired produce the mutations associated with non-melanoma skin cancer.
Broad-spectrum photoprotection is the single most evidence-supported intervention for preventing photoageing. A 2013 randomised controlled trial in Annals of Internal Medicine — the definitive Australian longitudinal photoageing trial — confirmed that daily sunscreen use prevented measurable photoageing over a 4.5-year period, with sunscreen users showing no detectable increase in skin ageing scores compared to significant progression in the control group.
Environmental and climate factors
Environmental humidity, air pollution, particulate matter and temperature extremes each impair skin function through specific, distinct mechanisms. Low humidity environments increase transepidermal water loss (TEWL), challenging the barrier's capacity to maintain skin hydration. Heating systems in winter create artificially low indoor humidity that compounds seasonal skin dryness far beyond what outdoor temperature alone would produce.
Ambient air pollution — particularly particulate matter PM2.5 and nitrogen dioxide (NO2) — has emerged as a significant independent driver of skin ageing and inflammatory skin conditions. A 2019 study in the Journal of Investigative Dermatology confirmed that long-term exposure to traffic-related air pollution was significantly associated with increased facial pigmentation spots (lentigines) and wrinkle depth, independent of UV exposure and other confounders. PM2.5 penetrates the stratum corneum directly, generating ROS within the epidermis and activating the same MMP-driven collagen degradation pathway as UV radiation.
Oxidative stress and antioxidant defence
The skin's antioxidant defence network comprises both enzymatic antioxidants (SOD, catalase, GPX) and dietary antioxidants (vitamins C and E, carotenoids, polyphenols). This network neutralises the ROS generated by UV exposure, environmental pollution, metabolic processes and inflammatory responses before they can damage cellular structures.
When oxidative burden exceeds antioxidant capacity — through high UV exposure, pollution, inadequate dietary antioxidants, genetic variants reducing antioxidant enzyme efficiency, or chronic inflammatory load — oxidative stress drives accelerated collagen degradation, lipid peroxidation in the barrier membrane and DNA damage accumulation. Dietary antioxidant loading through a diverse, plant-rich diet, targeted supplementation based on individual assessment, and topical antioxidant application collectively reduce the oxidative burden on skin and are among the most evidence-supported anti-ageing interventions available.
Is a systemic driver behind your skin condition?
A systemic skin consultation identifies thyroid, blood glucose and inflammatory drivers that standard skin assessments miss. Every enquiry begins with a complimentary 15-minute Discovery Call.
Book a complimentary Discovery Call Take the free skin assessmentReferences
- Safer JD. Thyroid hormone action on skin. Dermato-Endocrinology. 2011;3(3):211-215.
- Jabbour SA. Cutaneous manifestations of endocrine disorders: a guide for dermatologists. American Journal of Clinical Dermatology. 2003;4(5):315-331.
- Peppa M, Uribarri J, Vlassara H. Glucose, advanced glycation end products, and diabetes complications: what is new and what works. Clinical Diabetes. 2003;21(4):186-187.
- Monnier VM, Mustata GT, Biemel KL, et al. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes. Annals of the New York Academy of Sciences. 2005;1043:533-544.
- Natta MD, Lerais J, Saumet JL, et al. Thyroid skin changes: from hypothyroid to hyperthyroid. Annales de Dermatologie et de Venereologie. 2011;138(8-9):563-572.
- Vierkotter A, Schikowski T, Ranft U, et al. Airborne particle exposure and extrinsic skin aging. Journal of Investigative Dermatology. 2010;130(12):2719-2726.
- Naylor EC, Watson RE, Sherratt MJ. Molecular aspects of skin ageing. Maturitas. 2011;69(3):249-256.
- Hughes MC, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Annals of Internal Medicine. 2013;158(11):781-790.
- Poon F, Kang S, Chien AL. Mechanisms and treatments of photoaging. Photodermatology, Photoimmunology and Photomedicine. 2015;31(2):65-74.
- Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Archives of Dermatology. 2002;138(11):1462-1470.